Pfizer IncChange company Symbol lookupSelect an option...PFE Pfizer IncFUAPF Global Cannabis Applications CorpGXG Global X MSCI Colombia ETFATMR Altimar Acquisition Corp IIAMD Advanced Micro Devices IncBC-A BRUNSWICK 6 500 SENIOR NTSWST West Pharmaceutical Services IncITT ITT IncPLBY Plby Group IncSVFA SVF Investment CorpGo
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.
|
|
|
|
| |
PFE's position in the Pharmaceuticals industry
| Industry Peers | LLY | MRK | BMY | RETA | |
|---|---|---|---|---|---|
Summary | |||||
| Company Profile | Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical... | Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include... Go to LLY summary | Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through... Go to MRK summary | Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products... Go to BMY summary | Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of... Go to RETA summary |
| 52-Week Change | VS. INDUSTRY | 50.91% | -16.30% | 3.22% | 6.37% |
| Market Cap | VS. INDUSTRY | $220.1B | $181.4B | $136.2B | $4.0B |
| Beta | VS. INDUSTRY | 0.3 | 0.4 | 0.6 | 1.6 |
| Dividend Yield | VS. INDUSTRY | 1.48% | 3.63% | 3.20% | -- |
| P/E (TTM, GAAP) | VS. INDUSTRY | 34.58x | 37.94x | -- | -- |
| Data as of | |||||
Fundamentals | |||||
| Total Revenue (TTM) | VS. INDUSTRY | $26.7B | $47.1B | $44.4B | $7.8M |
| Profit Margin | VS. INDUSTRY | 22.71% | 10.23% | -11.40% | -3,499.45% |
| Earnings Growth (5 year, GAAP) | VS. INDUSTRY | 24.60% | 12.21% | -- | -- |
| Revenue Growth (TTM) | VS. INDUSTRY | 16.46% | -0.21% | 27.31% | -49.42% |
| Data as of |
Copyright © 2021. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.